Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CU01-1001 in type 2 diabetic nephropathy patients with albuminuria
KCT0004233Phase 2Completed
- Sponsor
- Curacle Co., Ltd.
- Start
- Sep 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of CU01-1001 in diabetic glomerulosclerosis, sponsored by Curacle Co., Ltd.. Started Sep 2019; status: completed.
02
Drugs
CU01-1001
03
Conditions
diabetic glomerulosclerosis
Beyond the preview
Go deeper on KCT0004233.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0004233.